Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (32)

2019

  1. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 394, Núm. 10193, pp. 121-130

  2. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

    The Lancet, Vol. 394, Núm. 10193, pp. 131-138

2015

  1. Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy Epidemiology of musculoskeletal disorders

    BMC Musculoskeletal Disorders, Vol. 16, Núm. 1

2014

  1. Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: A randomized, double-blind, placebo-controlled trial

    International Journal of Geriatric Psychiatry, Vol. 29, Núm. 9, pp. 978-986

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Functional impairment related to painful physical symptoms in patients with generalized anxiety disorder with or without comorbid major depressive disorder: Post hoc analysis of a cross-sectional study

    BMC Psychiatry, Vol. 11

  2. Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder

    Journal of Sexual Medicine, Vol. 8, Núm. 3, pp. 773-782

  3. Treatment-emergent sexual dysfunction with SSRIs and duloxetine: Effectiveness and functional outcomes over a 6-month observational period

    International Journal of Psychiatry in Clinical Practice, Vol. 15, Núm. 4, pp. 242-254

2010

  1. Back pain during different sequential treatment regimens of teriparatide: Results from EUROFORS

    Current Medical Research and Opinion, Vol. 26, Núm. 8, pp. 1799-1807

  2. Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: Prevalence of painful somatic symptoms, functioning and health status

    Journal of Affective Disorders, Vol. 127, Núm. 1-3, pp. 160-168

  3. Presence and predictors of pain in depression: Results from the FINDER study

    Journal of Affective Disorders, Vol. 125, Núm. 1-3, pp. 53-60

2009

  1. "Caseness" for depression and anxiety in a depressed outpatient population: Symptomatic outcome as a function of baseline diagnostic categories

    Primary Care Companion to the Journal of Clinical Psychiatry, Vol. 11, Núm. 6, pp. 307-315

  2. McLean-Harvard International First-Episode Project: Two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients

    Journal of Clinical Psychiatry, Vol. 70, Núm. 4, pp. 458-466

  3. Quality of life outcomes among patients with depression after 6 months of starting treatment: Results from FINDER

    Journal of Affective Disorders, Vol. 113, Núm. 3, pp. 296-302

  4. Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: Effects on painful physical symptoms of depression

    Journal of Psychiatric Research, Vol. 43, Núm. 5, pp. 512-518

2008

  1. Factors influencing depression endpoints research (FINDER): Study design and population characteristics

    European Psychiatry, Vol. 23, Núm. 1, pp. 57-65

  2. Prescribing patterns of antidepressants in Europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) study

    European Psychiatry, Vol. 23, Núm. 1, pp. 66-73

2007

  1. Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study

    Actas Espanolas de Psiquiatria, Vol. 35, Núm. 5, pp. 315-322

2006

  1. Duloxetine in the prevention of relapse of major depressive disorder: Double-blind placebo-controlled study

    British Journal of Psychiatry, Vol. 188, Núm. APR., pp. 346-353

  2. Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 Year follow-up naturalistic study

    Actas Espanolas de Psiquiatria, Vol. 34, Núm. 1, pp. 7-15